NSE · VINEETLAB
Vineet Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,136
of 5,004 stocks
🏆 New peak
▲ 471W
Peak #3,136 · 01 Oct 2026
Operating in Healthcare, Vineet Laboratories Limited is seeing revenue contract sharply, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 6%.
Market Cap
71.37 Cr
P/E Ratio
37.16
P/B Ratio
1.57
ROE
3.52%
ROCE
10.73%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 | Q1 2025-26 |
|---|---|---|---|---|
| Revenue | 18.89 Cr | 15.65 Cr | 17.42 Cr | 7.44 Cr |
| Net Profit | 1.22 Cr | 85.07 L | 40.10 L | -86.61 L |
| EPS | 0.43 | 0.92 | 0.43 | -0.94 |
| Operating Profit | 1.99 Cr | 1.91 Cr | 2.56 Cr | -28.94 L |
Shareholding pattern
Promoter
5.98%
Public
94.02%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 23 Dec 2025 | Rights | Rights 13:12 @ Premium Rs 20/- |
| 17 Sep 2024 | Other | Annual General Meeting |
| 18 Sep 2023 | Other | Annual General Meeting |
| 19 Sep 2022 | Dividend | Dividend - Re 1 Per Share |
| 22 Sep 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.